Verastem, Inc. SEC filings VSTM

Verastem, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Mar 8, 2012. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 4, 2026 Dec 31, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
10-K Annual report Mar 28, 2022 Dec 31, 2021
10-K Annual report Mar 18, 2021 Dec 31, 2020
10-K Annual report Mar 11, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 13, 2018 Dec 31, 2017
10-K Annual report Mar 23, 2017 Dec 31, 2016
10-K Annual report Mar 3, 2016 Dec 31, 2015
10-K Annual report Mar 10, 2015 Dec 31, 2014
10-K Annual report Mar 6, 2014 Dec 31, 2013
10-K Annual report Mar 26, 2013 Dec 31, 2012
10-K Annual report Mar 30, 2012 Dec 31, 2011

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VSTM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MA
Headquarters
Needham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1526119

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.